Glasdegib
Glasdegib acts as a potent, orally biovailablesmoothened (Smo) inhibitor used in the treatment of cancer.
Catalog Number | INT1095173275 |
Alternative Name(s) | EOS-60832;PF 04449913;1-((2R,4R)-2-(1H-benzo[d]iMidazol-2-yl)-1-Methylpiperidin-4-yl)-3-(4-cyanophenyl)urea;N-[(2R,4R)-2-(1H-Benzimidazol-2-yl)-1-methyl-4-piperidinyl]-N'-(4-cyanophenyl)urea;Glasdegib (PF-04449913);N-[(2R,4R)-2-(1H-Benzimidazol-2-yl)-1-methyl-4-piperidinyl]-N'-(4-cyanophenyl)urea PF 04449913;CS-1041 |
Research Area | Intermediates |
Molecular Formula | C21H22N6O |
CAS# | 1095173-27-5 |
Inchi Key | SFNSLLSYNZWZQG-VQIMIIECSA-N |
SMILES | N([C@@H]1CCN(C)[C@@H](C2NC3=CC=CC=C3N=2)C1)C(NC1=CC=C(C#N)C=C1)=O |
Size | inquiry |
Supplier Page | https://www.protheragen-ing.com/glasdegib-item-7635.html |